CH454887A - Verfahren zur Herstellung von Benzodiazepin-Derivaten - Google Patents

Verfahren zur Herstellung von Benzodiazepin-Derivaten

Info

Publication number
CH454887A
CH454887A CH1370566A CH1370566A CH454887A CH 454887 A CH454887 A CH 454887A CH 1370566 A CH1370566 A CH 1370566A CH 1370566 A CH1370566 A CH 1370566A CH 454887 A CH454887 A CH 454887A
Authority
CH
Switzerland
Prior art keywords
preparation
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Application number
CH1370566A
Other languages
English (en)
Inventor
A Archer Giles
Ian Fryer Rodney
Reeder Earl
Henryk Sternbach Leo
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CH454887A publication Critical patent/CH454887A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/26Preparation from compounds already containing the benzodiazepine skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1370566A 1962-03-02 1963-02-22 Verfahren zur Herstellung von Benzodiazepin-Derivaten CH454887A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17690162A 1962-03-02 1962-03-02

Publications (1)

Publication Number Publication Date
CH454887A true CH454887A (de) 1968-04-30

Family

ID=22646360

Family Applications (3)

Application Number Title Priority Date Filing Date
CH231263A CH438336A (de) 1962-03-02 1963-02-22 Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH5067A CH455815A (de) 1962-03-02 1963-02-22 Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH1370566A CH454887A (de) 1962-03-02 1963-02-22 Verfahren zur Herstellung von Benzodiazepin-Derivaten

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CH231263A CH438336A (de) 1962-03-02 1963-02-22 Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH5067A CH455815A (de) 1962-03-02 1963-02-22 Verfahren zur Herstellung von Benzodiazepin-Derivaten

Country Status (8)

Country Link
BE (1) BE629005A (de)
BR (1) BR6347108D0 (de)
CH (3) CH438336A (de)
CY (1) CY418A (de)
DE (1) DE1445874A1 (de)
GB (2) GB1040547A (de)
MY (1) MY6800032A (de)
SE (1) SE302127B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5218114A (en) * 1991-04-10 1993-06-08 Merck & Co., Inc. Cholecystokinin antagonists
DE19503320A1 (de) * 1995-02-02 1996-08-08 Boehringer Mannheim Gmbh Neue Benzodiazepinkonjugate

Also Published As

Publication number Publication date
CH438336A (de) 1967-06-30
SE302127B (de) 1968-07-08
GB1040547A (en) 1966-09-01
DE1445874A1 (de) 1970-07-23
CY418A (en) 1967-11-30
BE629005A (fr) 1963-08-28
GB1040548A (en) 1966-09-01
BR6347108D0 (pt) 1973-07-19
MY6800032A (en) 1968-12-31
CH455815A (de) 1968-05-15

Similar Documents

Publication Publication Date Title
CH450438A (de) Verfahren zur Herstellung von Benzodiazepinderivaten
CH436316A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH446360A (de) Verfahren zur Herstellung von Benzodiazepinderivaten
CH457465A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH445514A (de) Verfahren zur Herstellung von 6-Alkylmorphinan-Derivaten
CH438350A (de) Verfahren zur Herstellung von 6-Hydroxy-morphinan-Derivaten
CH443318A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH442326A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH457462A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH438339A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH455815A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH458374A (de) Verfahren zur Herstellung von Benzodiazepinderivaten
CH455814A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH457461A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH449031A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH455809A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH461515A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH469012A (de) Verfahren zur Herstellung von Benzodiazepinderivaten
CH459239A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH420176A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH411912A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH418344A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
CH434256A (de) Verfahren zur Herstellung von Piperideinoalkylguanidinderivaten
CH451167A (de) Verfahren zur Herstellung von 2-Alkoxycycloheptimidazolderivaten
AT238721B (de) Verfahren zur Herstellung von neuen Benzodiazepin-Derivaten